PhotoMedex regains compliance with Nasdaq minimum bid price requirement

PhotoMedex, Inc. (Nasdaq:PHMD) today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1).

On September 15, 2009, Nasdaq notified the Company that its common stock had failed to maintain a minimum bid price of $1.00 for the previous 30 consecutive business days as required by the Nasdaq Listing Rules. Nasdaq has informed the Company that for the last 10 business days, the closing bid price of the Company’s common stock has been at $1.00 per share or greater and accordingly the Company has regained compliance with Listing Rule 5450(a)(1).

SOURCE PhotoMedex

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.